secwatch.observer — SEC 8-K summary
======================================

Issuer:     Marker Therapeutics, Inc. (MRKR)
CIK:        0001094038
Form:       8-K
Filed at:   2026-05-04T23:59:59+00:00
Accession:  0001104659-26-054940
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Marker Therapeutics shareholders approve increase in authorized shares from 30M to 130M
--------------------------------------------------------------------------------

- Shareholders approved Charter Amendment to increase authorized common stock from 30M to 130M shares (10.9M for, 1.4M against).
- Proposal to revise voting threshold for share changes failed; broker non-votes prevented passage.
- All five director nominees re-elected; advisory vote on executive compensation passed.
- Ratification of CBIZ CPAs as independent auditor for fiscal 2026 approved by shareholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1094038/000110465926054940/0001104659-26-054940-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1094038/000110465926054940/tm2613511d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-054940

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer